Sunday July 23, 2017
Tories 4 the TransGender Community - The New Big Idea in the Big Tent - Gosh these folks are pathetic
The State pension, life expectancy and a ponzi the historically ignorant & innumerate left cannot understand
Considering my own mortality as the man fondled my testicles

PERSONAL, UNDILUTED VIEWS FROM TOM WINNIFRITH

, , , ,

Guest Post: Robert Sutherland Smith - AstraZeneca: asking questions of dividend policy?

Please share this article with your comrades in revolutionary capitalism

- Tom Winnifrith

Robert Sutherland Smith started his City career the year before I was born. He is, I think, 157 years old. He and I have worked together for almost eight years at t1ps.com . He is my friend and he is a very funny and intelligent chap. He is now branching out to celebrate his 158th by doing some freelance writing over at TradingResearchPoint on FTSE 350 Income stocks. He is a great one for focussing on yield. RSS today looks at AstraZeneca.

Whatever else, the annual results from that curiosity of the pharmaceutical sector, the Anglo-Swedish company AstraZeneca (AZN) tells us that the company’s management is thinking about dividend policy but presumably not telling us all they think. So here are my Hercule Poirot like surmises. Smoothing the waxed moustache, taking the cane from the umbrella stand and giving oneself an admiring glance in the art deco hall mirror, I mince forward, stimulating my little grey cells – such as they are – as I go.

Read the full article on TradingResearchPoint | Comments
---

Register here for The Tomograph
Tom's newsletter with original articles and a free share tip of the week, not found on this website.